Tudor Investment Corp
CINC

Tudor Investment Corp’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Tudor Investment Corp’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,836
Closed -$268K – 3108
2022
Q4 		$268K Buy
21,836
+31
+0.1% +$739 0.01% 1981
2022
Q3 		$716K Buy
+21,805
New +$616K 0.02% 1154

Tudor Investment Corp's CINC Position: Q1 2023 in Review

Tudor Investment Corp sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 21,836 shares — an estimated $268K sold.

Tudor Investment Corp first reported a position in CINC in Q3 2022 and held it in 2 quarters. The position peaked at $716K in Q3 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Tudor Investment Corp reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 21,836 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $268K.
  • Tudor Investment Corp first reported a position in CinCor Pharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Tudor Investment Corp's CinCor Pharma, Inc. Common Stock position peaked at $716K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.